Aurora Spine Announces Leadership Promotions: Matt Paxton, Executive Vice President of Sales and Katelyn Sims, Area Vice President of Commercialization and Key Accounts
Aurora Spine (TSXV: ASG) (OTCQB: ASAPF) has announced key leadership promotions, elevating Matt Paxton to Executive Vice President of Sales and Katelyn Sims to Area Vice President of Commercialization and Key Accounts.
As Executive Vice President of Sales, Paxton will lead company-wide initiatives focusing on operational excellence and strategic growth. Sims, in her new role as Area Vice President of Commercialization and Key Accounts, will oversee sales and market strategies implementation to expand the reach of Aurora Spine's products.
Matthew Goldstone, Chief Commercialization Officer, emphasized that these promotions align with Aurora Spine's 2025 goals and reflect the company's commitment to developing internal talent. The company, which designs and manufactures innovative medical devices for spinal surgery, aims to continue its focus on simplifying complex spinal procedures and delivering superior patient outcomes.
Aurora Spine (TSXV: ASG) (OTCQB: ASAPF) ha annunciato importanti promozioni nel leadership, elevando Matt Paxton a Vice Presidente Esecutivo delle Vendite e Katelyn Sims a Vice Presidente Area della Commercializzazione e dei Clienti Chiave.
In qualità di Vice Presidente Esecutivo delle Vendite, Paxton guiderà iniziative a livello aziendale focalizzate sull'eccellenza operativa e sulla crescita strategica. Sims, nel suo nuovo ruolo di Vice Presidente Area della Commercializzazione e dei Clienti Chiave, supervisionerà l'implementazione delle strategie di vendita e di mercato per ampliare la portata dei prodotti di Aurora Spine.
Matthew Goldstone, Chief Commercialization Officer, ha sottolineato che queste promozioni sono in linea con gli obiettivi del 2025 di Aurora Spine e riflettono il buon impegno dell'azienda nello sviluppo dei talenti interni. L'azienda, che progetta e produce dispositivi medici innovativi per la chirurgia spinale, mira a continuare a concentrarsi sulla semplificazione delle procedure spinali complesse e a fornire risultati superiori per i pazienti.
Aurora Spine (TSXV: ASG) (OTCQB: ASAPF) ha anunciado promociones clave en su liderazgo, elevando a Matt Paxton a Vicepresidente Ejecutivo de Ventas y a Katelyn Sims a Vicepresidenta de Área de Comercialización y Cuentas Clave.
Como Vicepresidente Ejecutivo de Ventas, Paxton liderará iniciativas a nivel de empresa enfocadas en la excelencia operativa y el crecimiento estratégico. Sims, en su nuevo rol como Vicepresidenta de Área de Comercialización y Cuentas Clave, supervisará la implementación de estrategias de ventas y mercado para ampliar la distribución de los productos de Aurora Spine.
Matthew Goldstone, Chief Commercialization Officer, enfatizó que estas promociones están alineadas con los objetivos de Aurora Spine para 2025 y reflejan el compromiso de la empresa para desarrollar talento interno. La compañía, que diseña y fabrica dispositivos médicos innovadores para cirugía de columna, busca continuar enfocándose en simplificar procedimientos espinales complejos y ofrecer resultados superiores para los pacientes.
오로라 스파인 (TSXV: ASG) (OTCQB: ASAPF)가 주요 리더십 승진을 발표했습니다. 매트 팩스톤이 영업 부사장으로 승진하고, 케이트린 심스가 상업화 및 주요 고객 부사장으로 승진했습니다.
영업 부사장으로서 팩스톤은 운영 우수성과 전략적 성장을 중심으로 하는 회사 전체 이니셔티브를 이끌 것입니다. 심스는 상업화 및 주요 고객의 새로운 역할에서 오로라 스파인의 제품 범위를 확장하기 위해 판매 및 시장 전략의 구현을 감독할 것입니다.
매튜 골드스톤, 최고 상업화 책임자는 이러한 승진이 오로라 스파인의 2025 목표와 일치하며, 회사의 내부 인재 개발에 대한 의지를 반영한다고 강조했습니다. 혁신적인 척추 수술용 의료 기기를 설계하고 제조하는 이 회사는 복잡한 척추 절차를 단순화하고 탁월한 환자 결과를 제공하는 데 집중할 계획입니다.
Aurora Spine (TSXV: ASG) (OTCQB: ASAPF) a annoncé des promotions clés au sein de sa direction, élevant Matt Paxton au poste de Vice-Président Exécutif des Ventes et Katelyn Sims au poste de Vice-Présidente de Zone de Commercialisation et de Comptes Clés.
En tant que Vice-Président Exécutif des Ventes, Paxton dirigera des initiatives à l'échelle de l'entreprise axées sur l'excellence opérationnelle et la croissance stratégique. Sims, dans son nouveau rôle de Vice-Présidente de Zone de Commercialisation et de Comptes Clés, supervisera la mise en œuvre des stratégies de vente et de marché pour étendre la portée des produits d'Aurora Spine.
Matthew Goldstone, Directeur de la Commercialisation, a souligné que ces promotions sont en adéquation avec les objectifs 2025 d'Aurora Spine et reflètent l'engagement de l'entreprise à développer des talents internes. L'entreprise, qui conçoit et fabrique des dispositifs médicaux innovants pour la chirurgie de la colonne vertébrale, vise à continuer de se concentrer sur la simplification des procédures de colonne complexes et à fournir des résultats supérieurs pour les patients.
Aurora Spine (TSXV: ASG) (OTCQB: ASAPF) hat wichtige Führungskräfte befördert und Matt Paxton zum Executive Vice President of Sales und Katelyn Sims zur Area Vice President of Commercialization and Key Accounts ernannt.
Als Executive Vice President of Sales wird Paxton unternehmensweite Initiativen leiten, die sich auf operative Exzellenz und strategisches Wachstum konzentrieren. Sims wird in ihrer neuen Rolle als Area Vice President of Commercialization and Key Accounts die Umsetzung von Verkaufs- und Marktstrategien überwachen, um die Reichweite der Produkte von Aurora Spine zu erweitern.
Matthew Goldstone, Chief Commercialization Officer, betonte, dass diese Beförderungen mit den Zielen von Aurora Spine für 2025 übereinstimmen und das Engagement des Unternehmens für die Entwicklung interner Talente widerspiegeln. Das Unternehmen, das innovative medizinische Geräte für die Wirbelsäulenchirurgie entwirft und herstellt, plant, sich weiterhin auf die Vereinfachung komplexer Wirbelsäuleneingriffe und die Bereitstellung überlegener Patientenergebnisse zu konzentrieren.
- None.
- None.
CARLSBAD, Calif., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the promotion of Matt Paxton to Executive Vice President of Sales and Katelyn Sims to Area Vice President of Commercialization and Key Accounts. These strategic appointments underscore Aurora Spine’s commitment to developing world-class talent. Both Matt and Katelyn’s commitment to excellence, innovation, and delivering exceptional patient outcomes have been the cornerstone of their success.
Mr. Paxton and Ms. Sims embody Aurora Spine’s purpose-driven mentality, bringing a relentless focus on innovation and patient-centric care to their new roles. Through their dedication and hard work, both leaders have played pivotal roles in advancing Aurora Spine’s mission to revolutionize spinal healthcare with cutting-edge solutions that improve the quality of life for patients worldwide.
As Executive Vice President of Sales, Mr. Paxton will spearhead company-wide initiatives, leveraging his expertise to drive operational excellence and strategic growth. Over the years, Mr. Paxton has demonstrated an unwavering commitment to Aurora Spine’s vision, playing a key role in fostering a culture of collaboration, innovation, and accountability.
Ms. Sims, as Area Vice President of Commercialization and Key Accounts, will oversee the implementation of dynamic sales and market strategies, ensuring that Aurora Spine’s groundbreaking products continue to reach healthcare providers and patients in need. With a proven track record of building strong partnerships and a passion for making a difference, Ms. Sims is poised to elevate Aurora Spine’s impact across the healthcare ecosystem.
“Aurora Spine’s success is rooted in the dedication of our team, and Matt and Katelyn exemplify the leadership we need to achieve our ambitious goals for 2025,” said Matthew Goldstone, Chief Commercialization Officer of Aurora Spine. “Their commitment to innovation and patient outcomes will undoubtedly propel our company forward as we continue to disrupt the spine care industry.”
Both promotions reflect Aurora Spine’s strategic focus on enhancing its leadership team to capitalize on the opportunities ahead. The company remains steadfast in its mission to develop transformative products and solutions that address unmet needs in spinal healthcare. With a focus on simplifying complex spinal procedures, Aurora Spine’s advanced product portfolio is trusted by healthcare professionals worldwide to deliver superior outcomes for their patients.
About Aurora Spine
Aurora Spine is focused on bringing new solutions to the spinal implant and pain care markets through a series of screwless, innovative, minimally invasive, regenerative spinal implant technologies. Additional information can be accessed at www.aurora-spine.com or www.aurorapaincare.com.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus (collectively, "forward-looking information"). Forward-looking information in this news release includes information concerning the proposed use and success of the company’s products in surgical procedures. Aurora Spine cautions investors of Aurora Spine's securities about important factors that could cause Aurora Spine's actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward-looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.
Contact:
Aurora Spine Corporation
Trent Northcutt
President and Chief Executive Officer
(760) 424-2004
Chad Clouse
Chief Financial Officer
(760) 424-2004
www.aurora-spine.com
FAQ
What recent leadership changes were announced at Aurora Spine (ASAPF) in January 2025?
What will be Matt Paxton's responsibilities in his new role at Aurora Spine (ASAPF)?
What is Katelyn Sims' new position at Aurora Spine (ASAPF)?
How do these promotions align with Aurora Spine's (ASAPF) strategic goals for 2025?
